Long-term HIV Treatment May Reduce Risk For Atherosclerosis

Antiretroviral drugs for HIV do not increase risk of coronary atherosclerosis says a University of Pittsburgh Graduate School of Public Health study. The results, based on nearly 950 HIV-positive and HIV-negative men, suggest that antiretroviral therapy may, in fact, offer men with HIV some protection against atherosclerosis. Coronary artery calcification scores were almost 60 percent lower in HIV-positive men who received highly active antiretroviral therapy for more than eight years compared to HIV-negative men.

Read the whole article on Science Daily

More from Science Daily